Assenagon Asset Management
SRRA

Assenagon Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Assenagon Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,235
Closed -$19K – 996
2019
Q3 		$19K Sell
1,235
-8
-0.6% -$153 ﹤0.01% 808
2019
Q2 		$28K Buy
+1,243
New +$60.2K ﹤0.01% 979

Other funds holding SRRA

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Assenagon Asset Management's SRRA Position: Q4 2019 in Review

Assenagon Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2019, closing a stake of 1,235 shares — an estimated $19K sold.

Assenagon Asset Management first reported a position in SRRA in Q2 2019 and held it in 2 quarters. The position peaked at $28K in Q2 2019. 29 funds tracked by Wall St. Rank hold SRRA as of Q4 2019.

  • Assenagon Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 1,235 Sierra Oncology, Inc. Common Stock shares in Q4 2019, an estimated $19K.
  • Assenagon Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Assenagon Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $28K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2019.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.